CXCL13 and common variable immunodeficiency: However, this gender difference disappeared after excluding outlier female patients with the highest CXCL13 levels and complication burden (Figs. 6 and S4), and adjusting for gender did not alter the association between CXCL13 and CVID-related complications (Table 2).